Quilaban participated in ATTD 2026 – Advanced Technologies & Treatments for Diabetes, in Barcelona, one of the largest international congresses dedicated to technological innovation in the field of diabetes, reinforcing its commitment to the continuous evolution of healthcare.
Quilaban was present at ATTD 2026 – Advanced Technologies & Treatments for Diabetes, which took place in Barcelona between 11th and 14th March. The event brought together specialists, researchers and leading companies in the field of diabetology worldwide.
During the congress, the Quilaban team had the opportunity to engage with international Key Opinion Leaders (KOLs) and meet with strategic partners, closely following the latest technological innovations and trends in diabetes treatment and monitoring. This moment enabled Quilaban to strengthen its connection to the global innovation ecosystem in the sector.
Participation in ATTD 2026 reflects Quilaban’s commitment to bringing differentiating solutions and approaches to Portugal, aligned with its strategy. This makes it easier to meet the needs of healthcare professionals and people living with diabetes, contributing to better care and greater quality of life.